Clinical evaluation of PF614, a novel TAAP prodrug of oxycodone, versus OxyContin in a multi‐ascending dose study with a bioequivalence arm in healthy volunteers
- DOI
- 10.1111/cts.13765
- Published
- 2024-03
- Container
- Clinical and Translational Science
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/cts.13765,
title = {Clinical evaluation of PF614, a novel TAAP prodrug of oxycodone, versus OxyContin in a multi‐ascending dose study with a bioequivalence arm in healthy volunteers},
author = {D. Lynn Kirkpatrick and Cari Evans and Linda A. Pestano and Jeffrey Millard and Matthew Johnston and Emily Mick and William K. Schmidt},
year = {2024},
journal = {Clinical and Translational Science},
doi = {10.1111/cts.13765},
url = {https://doi.org/10.1111/cts.13765}
}RIS
TY - JOUR TI - Clinical evaluation of PF614, a novel TAAP prodrug of oxycodone, versus OxyContin in a multi‐ascending dose study with a bioequivalence arm in healthy volunteers AU - D. Lynn Kirkpatrick AU - Cari Evans AU - Linda A. Pestano AU - Jeffrey Millard AU - Matthew Johnston AU - Emily Mick AU - William K. Schmidt PY - 2024 JO - Clinical and Translational Science DO - 10.1111/cts.13765 UR - https://doi.org/10.1111/cts.13765 ER -
APA
Kirkpatrick, D. L., Evans, C., Pestano, L. A., Millard, J., Johnston, M., Mick, E., & Schmidt, W. K. (2024). Clinical evaluation of PF614, a novel TAAP prodrug of oxycodone, versus OxyContin in a multi‐ascending dose study with a bioequivalence arm in healthy volunteers. Clinical and Translational Science. https://doi.org/10.1111/cts.13765
Source records
- crossref · retrieved 2026-09-26T17:40:28.461Z